Although recommended by international guidelines, the benefit of inspiratory muscle training (IMT) in addition to rehabilitation remains uncertain. The objective was to demonstrate the effectiveness of IMT on dyspnea using Borg scale and multidimensional dyspnea profile questionnaire at the end of a 6-minute walk test (6MWT) in patients with chronic obstructive pulmonary disease (COPD) with preserved average maximum inspiratory pressure (PI_max) of 85 cm H₂O (95% of predicted (pred.) value) and admitted for a rehabilitation program in a dedicated center. In a randomized trial, comparing IMT versus no IMT in 32 COPD patients without inspiratory muscle weakness (PI_max >60 cm H₂O) who were admitted for pulmonary rehabilitation (PR) for 3 weeks, we evaluated the effect of IMT on dyspnea, using both Borg scale and multidimensional dyspnea profile (MDP) at the end of the 6MWT, and on functional parameters included inspiratory muscle function (PI_max) and 6MWT. All testings were performed at the start and the end of PR. In unadjusted analysis, IMT was not found to be associated with an improvement of either dyspnea or PI_max. After adjustment on confounders (initial Borg score) and variables of interaction (forced expiratory volume in 1 second (FEV₁)), we found a trend toward an improvement of “dyspnea sensory intensity”, items from MDP and a significant improvement on the variation in the 2 items of MDP (“tight or constricted” and “breathing a lot”). In the subgroup of patients with FEV₁ < 50% pred., 5 items of MDP were significantly improved, whereas no benefit was observed in patients with FEV₁ > 50% pred. IMT did not significantly improve dyspnea or functional parameter in COPD patients with PI_max > 60 cm H₂O. However, in the subgroup of patients with FEV₁ < 50% pred., MDP was significantly improved.